经导管动脉栓塞联合外科手术治疗肝血管瘤40例临床分析  

Clinical Application of TAE Combined with Surgery in the Treatment of Liver Cavernous Hemangioma in 40 Cases

作　　者：滕毅山[1] 王家平[2] 童玉云[2] 孔鹏[2] 杨青[2] 江华[2] 

机构地区：[1]昆明医学院第二附属医院腹部微创外科,云南昆明650101 [2]昆明医学院第二附属医院放射科介入室,云南昆明650101

出　　处：《昆明医学院学报》2011年第9期34-37,共4页Journal of Kunming Medical College

基　　金：云南省科技计划基金资助项目(2009ZC111M);云南省教育厅科学研究基金资助项目(601090200506)

摘　　要：目的比较外科手术与经导管动脉栓塞法(TAE)治疗肝血管瘤患者的疗效和术后并发症,探讨肝血管瘤治疗方法的合理选择.方法 40例肝血管瘤(CHL)患者随机分为介入组与介入加手术组(综合组),介入组20例,行TACE 1～5次,平均3.5次;综合组20例,先行TACE 1～4次,平均3.1次,2～4周后行手术治疗.结果综合组与介入组1 a、2 a生存率分别为90%、76%和78.6%、40%,两组生存率比较差异有统计学意义(P<0.05).结论 CHL疗效介入加手术治疗优于单纯行TACE治疗,能有效提高生存期,不良反应轻微,是治疗中晚期肝癌的有效方法之一.Objective To evaluate the effect of TAE combined with surgery on cavernous hemangioma of liver（CHL）.Methods 40 patients with CHL were divided into 2 groups：group A and group B,20 cases in each group.Patients in Group A were treated by TACE for 1～ 4 times with the average value of 3.5 times.Patients in Group B were treated by TACE for 1～ 5 times with the average value of 3.1 times firstly,and 2～ 4 weeks later,accepted the therapy of surgery operation.Results The survival rate was 90% in 1 year and 76% in 2 years in group B and 78.6% and 40% in group A,respectively.The difference between 2 groups was statistically significant（P0.05）.Conclusion The treatment of CHL by TACE in combination with surgery can improve the survival rate of patients,which should be advocated for its excellent results and low rate of complications.

关 键 词：肝血管瘤 手术治疗 介人治疗 

分 类 号：R735.7[医药卫生—肿瘤]